| Name | Lincare Inc |
|---|---|
| Organization Name | Lincare Inc |
| Location | 712 George St, Athens, Tennessee 37303 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (423) 744-8835 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In a U.S. News & World Report opinion piece, African Health Ministers Aaron Motsoaledi of South Africa, Mphu Ramatlapeng of Lesotho, and Benedict Xaba of Swaziland call upon the international community to join with them in the fight to rid the world of tuberculosis (TB). "That goal might seem overambitious or unrealistic. [But i]t's not," they write
Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.
Johns Hopkins researchers have dispelled the widespread belief among obstetricians that, in premature infants, brain injury results from a lack of oxygen, also called hypoxia, when, in fact, infection plays a larger role.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
Few women are consulting their doctors before opting to use herbal therapies and soy products to treat their menopausal symptoms, researchers at the Stanford University School of Medicine have found.
› Verified 9 days ago
| NPI Number | 1194890301 |
| Organization Name | LINCARE INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 712 George St, Athens, TN 37303 |
| Phone Number | 423-744-8835 |
News Archive
In a U.S. News & World Report opinion piece, African Health Ministers Aaron Motsoaledi of South Africa, Mphu Ramatlapeng of Lesotho, and Benedict Xaba of Swaziland call upon the international community to join with them in the fight to rid the world of tuberculosis (TB). "That goal might seem overambitious or unrealistic. [But i]t's not," they write
Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.
Johns Hopkins researchers have dispelled the widespread belief among obstetricians that, in premature infants, brain injury results from a lack of oxygen, also called hypoxia, when, in fact, infection plays a larger role.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
Few women are consulting their doctors before opting to use herbal therapies and soy products to treat their menopausal symptoms, researchers at the Stanford University School of Medicine have found.
› Verified 9 days ago
News Archive
In a U.S. News & World Report opinion piece, African Health Ministers Aaron Motsoaledi of South Africa, Mphu Ramatlapeng of Lesotho, and Benedict Xaba of Swaziland call upon the international community to join with them in the fight to rid the world of tuberculosis (TB). "That goal might seem overambitious or unrealistic. [But i]t's not," they write
Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.
Johns Hopkins researchers have dispelled the widespread belief among obstetricians that, in premature infants, brain injury results from a lack of oxygen, also called hypoxia, when, in fact, infection plays a larger role.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
Few women are consulting their doctors before opting to use herbal therapies and soy products to treat their menopausal symptoms, researchers at the Stanford University School of Medicine have found.
› Verified 9 days ago
Ingles Pharmacy #088 Type: Community/Retail Pharmacy Location: 917 Decatur Pike, Athens, Tennessee 37303 Phone: (423) 744-1085 | |
Madison Avenue Pharmacy Type: Community/Retail Pharmacy Location: 1001 W Madison Ave, Athens, Tennessee 37303 Phone: (423) 746-2626 | |
Food City Pharmacy #686 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 105 S Hill St, Athens, Tennessee 37303 Phone: (423) 507-0921 | |
Keylon Eyecare Type: Medicare Supplier Location: 902 W Madison Ave, Athens, Tennessee 37303 Phone: (423) 745-8882 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 712 George St, Athens, Tennessee 37303 Phone: (423) 744-8835 |